BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 23288242)

  • 1. Serum brain-derived neurotrophic factor levels at 6 months after remission are not associated with subsequent depressive episodes.
    Yoshimura R; Hori H; Sugita-Ikenouchi A; Umene-Nakano W; Katsuki A; Nakamura J
    J Clin Psychopharmacol; 2013 Feb; 33(1):142-3. PubMed ID: 23288242
    [No Abstract]   [Full Text] [Related]  

  • 2. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression.
    Mikoteit T; Beck J; Eckert A; Hemmeter U; Brand S; Bischof R; Holsboer-Trachsler E; Delini-Stula A
    Psychopharmacology (Berl); 2014 Aug; 231(15):2955-65. PubMed ID: 24562062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Brain-Derived Neurotrophic Factors in Taiwanese Patients with Drug-Naïve First-Episode Major Depressive Disorder: Effects of Antidepressants.
    Chiou YJ; Huang TL
    Int J Neuropsychopharmacol; 2017 Mar; 20(3):213-218. PubMed ID: 27811136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodological approach to brain-derived neurotrophic factor plasma levels in major depressed patients receiving duloxetine.
    Agilli M; Aydin FN
    Neurol Sci; 2015 Jun; 36(6):1061-2. PubMed ID: 25637063
    [No Abstract]   [Full Text] [Related]  

  • 6. Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression.
    Dreimüller N; Schlicht KF; Wagner S; Peetz D; Borysenko L; Hiemke C; Lieb K; Tadić A
    Neuropharmacology; 2012 Jan; 62(1):264-9. PubMed ID: 21803060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of last depressive episode may influence serum BDNF levels in remitted patients with major depression.
    Takebayashi N; Maeshima H; Baba H; Nakano Y; Satomura E; Kita Y; Namekawa Y; Nomoto H; Suzuki T; Arai H
    Depress Anxiety; 2012 Sep; 29(9):775-9. PubMed ID: 22447660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma brain-derived neurotrophic factor (pBDNF) and executive dysfunctions in patients with major depressive disorder.
    Wagner S; Kayser S; Engelmann J; Schlicht KF; Dreimüller N; Tüscher O; Müller-Dahlhaus F; Braus DF; Tadić A; Neyazi A; Frieling H; Lieb K
    World J Biol Psychiatry; 2019 Sep; 20(7):519-530. PubMed ID: 29334322
    [No Abstract]   [Full Text] [Related]  

  • 10. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode.
    Gervasoni N; Aubry JM; Bondolfi G; Osiek C; Schwald M; Bertschy G; Karege F
    Neuropsychobiology; 2005; 51(4):234-8. PubMed ID: 15897674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between brain-derived neurotrophic factor plasma levels and severity of the illness, recurrence and symptoms in depressed patients.
    Dell'Osso L; Del Debbio A; Veltri A; Bianchi C; Roncaglia I; Carlini M; Massimetti G; Catena Dell'Osso M; Vizzaccaro C; Marazziti D; Piccinni A
    Neuropsychobiology; 2010; 62(4):207-12. PubMed ID: 20714169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: a pilot study.
    Tadić A; Wagner S; Schlicht KF; Peetz D; Borysenko L; Dreimüller N; Hiemke C; Lieb K
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):415-20. PubMed ID: 20732374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects.
    Neumeister A; Yuan P; Young TA; Bonne O; Luckenbaugh DA; Charney DS; Manji H
    Am J Psychiatry; 2005 Apr; 162(4):805-7. PubMed ID: 15800160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma dehydroepiandrosterone sulfate levels in patients with major depressive disorder correlate with remission during treatment with antidepressants.
    Morita T; Senzaki K; Ishihara R; Umeda K; Iwata N; Nagai T; Hida H; Nabeshima T; Yukawa K; Ozaki N; Noda Y
    Hum Psychopharmacol; 2014 May; 29(3):280-6. PubMed ID: 24911578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients.
    Gonul AS; Akdeniz F; Taneli F; Donat O; Eker C; Vahip S
    Eur Arch Psychiatry Clin Neurosci; 2005 Dec; 255(6):381-6. PubMed ID: 15809771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery from a recurrent major depressive episode.
    Kravitz HM; Bloom RW; Fawcett J
    Depress Anxiety; 2000; 12(1):40-3. PubMed ID: 10999244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments.
    Piccinni A; Marazziti D; Catena M; Domenici L; Del Debbio A; Bianchi C; Mannari C; Martini C; Da Pozzo E; Schiavi E; Mariotti A; Roncaglia I; Palla A; Consoli G; Giovannini L; Massimetti G; Dell'Osso L
    J Affect Disord; 2008 Jan; 105(1-3):279-83. PubMed ID: 17553570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
    Huang TL; Lee CT; Liu YL
    J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BDNF plasma levels variations in major depressed patients receiving duloxetine.
    Fornaro M; Escelsior A; Rocchi G; Conio B; Magioncalda P; Marozzi V; Presta A; Sterlini B; Contini P; Amore M; Fornaro P; Martino M
    Neurol Sci; 2015 May; 36(5):729-34. PubMed ID: 25501804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
    Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
    Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.